News

BioWorld12h
Merck wins FDA approval in pediatric RSV and steps into CDC uncertainty
With the U.S. FDA’s approval of Enflonsia (cesrovimab) to prevent respiratory syncytial virus (RSV) infection lower ...
Newly approved antibody could offer another option for protecting infants from RSV, a common infection that can be deadly
The United States could soon have another tool in the fight against respiratory syncytial virus, an illness that’s the No. 1 ...
Becker's Hospital Review11h
FDA OKs antibody to protect against RSV in infants
The FDA has approved Merck’s Enflonasia, a monoclonal antibody designed to prevent respiratory syncytial virus lower respiratory tract disease in newborns and infants. The approval is based on data ...
It has been a long, deadly flu season in Arizona and the virus is still here
The flu virus is lingering in Arizona and the season has been vicious. Pediatric flu deaths reached the highest level in ...
Becker's Hospital Review4h
RFK Jr. names new members to CDC’s vaccine panel
HHS Secretary Robert F. Kennedy Jr. named eight new members to the CDC panel that oversees vaccine recommendations June 11. The appointments come two days after HHS terminated all 17 members of the ...
FDA approves new RSV treatment for infants
CHARLOTTE — The Food and Drug Administration approved a new vaccine to help protect infants from RSV on Monday. The treatment ...